Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Jorgensen

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
BMJ Open Gastroenterology|April 26, 2016
Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH)Kashmira S Chawla, Jayant A Talwalkar, Jill C Keach, et al.
Hepatology (Baltimore, Md.)|February 5, 2002
Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acidSupriya Joshi, Karen Cauch-Dudek, Ian R Wanless, et al.
The American Journal of Gastroenterology|August 2, 2006
Elevated serum IgG4 concentration in patients with primary sclerosing cholangitisFlavia D Mendes, Roberta Jorgensen, Jill Keach, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 20, 2009
Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-upEinar Björnsson, Evangelos Kalaitzakis, Matthias Neuhauser, et al.
Journal of Gastroenterology and Hepatology|April 23, 2002
Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosisManuela Neuman, Paul Angulo, Izabella Malkiewicz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 4, 2011
Long-term outcomes of patients with primary biliary cirrhosis and hepatocellular carcinomaMohamad H Imam, Marina G Silveira, Emmanouil Sinakos, et al.
American Journal of Therapeutics|June 11, 2014
Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing CholangitisJames H Tabibian, Andrea Gossard, Mounif El-Youssef, et al.
Hepatology (Baltimore, Md.)|March 5, 2004
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trialKeith D Lindor, Kris V Kowdley, E Jenny Heathcote, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 19, 2010
A short version of a HRQoL questionnaire for Italian and Japanese patients with Primary Biliary CirrhosisLorenzo Montali, Atsushi Tanaka, Paolo Riva, et al.
The American Journal of Gastroenterology|May 11, 2011
High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitisJohn E Eaton, Marina G Silveira, Darrell S Pardi, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
BMJ Open Gastroenterology|April 26, 2016
Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH)Kashmira S Chawla, Jayant A Talwalkar, Jill C Keach, et al.
Hepatology (Baltimore, Md.)|February 5, 2002
Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acidSupriya Joshi, Karen Cauch-Dudek, Ian R Wanless, et al.
The American Journal of Gastroenterology|August 2, 2006
Elevated serum IgG4 concentration in patients with primary sclerosing cholangitisFlavia D Mendes, Roberta Jorgensen, Jill Keach, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 20, 2009
Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-upEinar Björnsson, Evangelos Kalaitzakis, Matthias Neuhauser, et al.
Journal of Gastroenterology and Hepatology|April 23, 2002
Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosisManuela Neuman, Paul Angulo, Izabella Malkiewicz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 4, 2011
Long-term outcomes of patients with primary biliary cirrhosis and hepatocellular carcinomaMohamad H Imam, Marina G Silveira, Emmanouil Sinakos, et al.
American Journal of Therapeutics|June 11, 2014
Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing CholangitisJames H Tabibian, Andrea Gossard, Mounif El-Youssef, et al.
Hepatology (Baltimore, Md.)|March 5, 2004
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trialKeith D Lindor, Kris V Kowdley, E Jenny Heathcote, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 19, 2010
A short version of a HRQoL questionnaire for Italian and Japanese patients with Primary Biliary CirrhosisLorenzo Montali, Atsushi Tanaka, Paolo Riva, et al.
The American Journal of Gastroenterology|May 11, 2011
High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitisJohn E Eaton, Marina G Silveira, Darrell S Pardi, et al.
Pageof 3